BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,649,000 | -11.2% | 39,207 | +3.2% | 0.05% | 0.0% |
| Q4 2021 | $5,238,000 | +115.5% | 38,007 | +117.2% | 0.05% | +116.0% |
| Q3 2021 | $2,431,000 | -30.4% | 17,500 | -51.4% | 0.02% | -26.5% |
| Q2 2021 | $3,495,000 | +42.0% | 36,000 | 0.0% | 0.03% | +30.8% |
| Q1 2021 | $2,461,000 | +129.8% | 36,000 | +188.0% | 0.03% | +116.7% |
| Q4 2020 | $1,071,000 | -32.8% | 12,500 | -49.0% | 0.01% | -45.5% |
| Q3 2020 | $1,593,000 | +88.7% | 24,500 | -1.2% | 0.02% | +37.5% |
| Q1 2020 | $844,000 | -31.7% | 24,800 | +9.3% | 0.02% | -20.0% |
| Q4 2019 | $1,236,000 | – | 22,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |